These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25451712)

  • 21. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review.
    Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
    Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries.
    Nelson AT; Harris AK; Watson D; Kamihara J; Chen KS; Stall JN; Devins KM; Young RH; Olson DR; Mallinger PHR; Mitchell SG; Hoffman LM; Halliday G; Suleymanova AM; Glade Bender JL; Messinger YH; Herzog CE; Field AL; Frazier AL; Stewart DR; Dehner LP; Hill DA; Billmire DF; Schneider DT; Schultz KAP
    Gynecol Oncol; 2024 Jul; 186():117-125. PubMed ID: 38657450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on the central nervous system manifestations of DICER1 syndrome.
    de Kock L; Priest JR; Foulkes WD; Alexandrescu S
    Acta Neuropathol; 2020 Apr; 139(4):689-701. PubMed ID: 30953130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome.
    Slade I; Bacchelli C; Davies H; Murray A; Abbaszadeh F; Hanks S; Barfoot R; Burke A; Chisholm J; Hewitt M; Jenkinson H; King D; Morland B; Pizer B; Prescott K; Saggar A; Side L; Traunecker H; Vaidya S; Ward P; Futreal PA; Vujanic G; Nicholson AG; Sebire N; Turnbull C; Priest JR; Pritchard-Jones K; Houlston R; Stiller C; Stratton MR; Douglas J; Rahman N
    J Med Genet; 2011 Apr; 48(4):273-8. PubMed ID: 21266384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of DICER1 pathogenic variation in population databases.
    Kim J; Field A; Schultz KAP; Hill DA; Stewart DR
    Int J Cancer; 2017 Nov; 141(10):2030-2036. PubMed ID: 28748527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reclassification of two germline DICER1 splicing variants leads to DICER1 syndrome diagnosis.
    Apellaniz-Ruiz M; Sabbaghian N; Chong AL; de Kock L; Cetinkaya S; Bayramoğlu E; Dinjens WNM; McCluggage WG; Wagner A; Yilmaz AA; Foulkes WD
    Fam Cancer; 2023 Oct; 22(4):487-493. PubMed ID: 37248399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
    Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
    Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree.
    Fernández-Martínez L; Villegas JA; Santamaría Í; Pitiot AS; Alvarado MG; Fernández S; Torres H; Paredes Á; Blay P; Balbín M
    BMC Cancer; 2017 Feb; 17(1):146. PubMed ID: 28222777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimorbidity and Genetic Characteristics of DICER1 Syndrome Based on Systematic Review.
    Cai S; Zhao W; Nie X; Abbas A; Fu L; Bihi S; Feng G; Liu T; Lv Y; Ma X; Peng X
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):355-361. PubMed ID: 27906793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
    Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DICER1 Syndrome.
    Hořínová V; Drábová K; Nosková H; Bajčiová V; Šoukalová J; Černá L; Hůrková V; Slabý O; Štěrba J
    Klin Onkol; 2019; 32(Supplementum2):123-127. PubMed ID: 31409088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DICER1 syndrome: a new cancer syndrome.
    Schultze-Florey RE; Graf N; Vorwerk P; Koscielniak E; Schneider DT; Kratz CP
    Klin Padiatr; 2013 May; 225(3):177-8. PubMed ID: 23625684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms.
    McCluggage WG; Chong AL; de Kock L; Foulkes WD
    Histopathology; 2020 Aug; 77(2):223-230. PubMed ID: 32333409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DICER1 syndrome can mimic different genetic tumor predispositions.
    Mehraein Y; Schmid I; Eggert M; Kohlhase J; Steinlein OK
    Cancer Lett; 2016 Jan; 370(2):275-8. PubMed ID: 26577641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gynecologic Manifestations of the DICER1 Syndrome.
    Stewart CJ; Charles A; Foulkes WD
    Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations.
    Bardón-Cancho EJ; Haro-Díaz A; Alonso-García-de la Rosa FJ; Huerta-Aragonés J; García-Morín M; González-Martínez F; Garrido-Colino C
    Fam Cancer; 2017 Apr; 16(2):291-294. PubMed ID: 27830405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.
    Garcia A; Desrosiers L; Scollon S; Gruner S; Reuther J; Gandhi I; Patil N; Fuller MY; Dai H; Muzny D; Gibbs RA; Bercaw-Pratt JL; Rao SL; Rainusso N; Fisher KE; Lin FY; Plon SE; Parsons DW; Roy A
    Cancer Genet; 2022 Apr; 262-263():53-56. PubMed ID: 35026696
    [No Abstract]   [Full Text] [Related]  

  • 40. Deep Sequencing Reveals Spatially Distributed Distinct Hot Spot Mutations in DICER1-Related Multinodular Goiter.
    de Kock L; Bah I; Revil T; Bérubé P; Wu MK; Sabbaghian N; Priest JR; Ragoussis J; Foulkes WD
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3637-3645. PubMed ID: 27459524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.